Metronidazole
- Product NDC
- 16571-665
- 11-digit product format
- 165710665
- Labeler code
- 16571
- Product ID
- 16571-665_241c7c4c-5fd9-4c0e-b7b7-4094f77e9721
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metronidazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharma Holdings, Inc.
- Application
- ANDA203974
- Marketing category
- ANDA
- Marketing start
- 2015-05-29
- Substance
- METRONIDAZOLE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203974-001 | METRONIDAZOLE | METRONIDAZOLE | 250MG | TABLET / ORAL | AB | 2015-05-29 | |
| A203974-002 | METRONIDAZOLE | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | RS | 2015-05-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203974-001 | AB |
| A203974-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203974-001 | METRONIDAZOLE | 250MG | TABLET / ORAL | AB | 2015-05-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A203974-002 | METRONIDAZOLE | 500MG | TABLET / ORAL | AB | RS | 2015-05-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203974-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A203974-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | c225a455-ec25-2213-e053-2995a90a3389 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | dc28753c-95ec-4b41-ad77-c4a66698d9db | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 2fa14353-45df-429c-8759-7d66a65f08f0 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 92e58420-1d99-4a92-b1f3-a7f791ca7187 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 |
| Metronidazole | METRONIDAZOLE | Rising Pharma Holdings, Inc. | 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 16571-665 |
| Metronidazole | METRONIDAZOLE | Aurobindo Pharma Limited | f68397ee-67db-472e-8607-4300064e37df | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | bff2f5bd-75a4-4252-a643-c21741ae8a96 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 203974 ANDA203974 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metronidazole
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METRONIDAZOLE | 250 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 140QMO216E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8ffb9b1d-3ed7-ba2e-677e-47d4d134fd55 | Product name | 5 | 20251024 |
| 7f6d14e0-4366-41bc-a4a9-b74c79a20e17 | Product name | 1 | 20250623 |
| e6d321b0-0e5e-7da6-f043-92b6a91f00a1 | Product name | 5 | 20250515 |
| e1aac33b-94ae-4ee9-905b-299f7263853b | Product name | 3 | 20250124 |
| 16642716-d28a-4f90-8dcb-3921cd8c8109 | Product name | 4 | 20240516 |
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| a5070875-62bb-61e1-fd46-8f7054197a40 | Product name | 8 | 20180215 |
| 0add4de9-d152-3375-3390-1123dddc5e3d | Product name | 1 | 20140508 |
| 33ca0fcc-1011-92dc-50a9-a383683eed1e | Product name | 1 | 20140508 |
| 53f39d9f-cd3f-04e1-c668-d4580719d57d | Product name | 1 | 20140508 |
| a804000f-b74f-0b5d-d17b-aa767c286ddb | Product name | 1 | 20140508 |
| a91ea265-6e02-c08f-93c8-686d54180529 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16571-665-01 | Metronidazole | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 16571-665-50 | Metronidazole | 500 in 1 BOTTLE | TABLET | 500 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16571-665-01 | EA - Each | 16571-665 | 66e71a37-6766-462c-91cd-4e3481c8077f | 1 | 2020-06-05 |
| 16571-665-50 | EA - Each | 16571-665 | 45a3a143-ed32-432b-9b5f-5899dbddfdf7 | 1 | 2020-06-05 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | 2fa14353-45df-429c-8759-7d66a65f08f0 | 105 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | 2fa14353-45df-429c-8759-7d66a65f08f0 | 105 |
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | 7 |
| 311681 | metroNIDAZOLE 500 MG Oral Tablet | PSN | 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | 7 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | 7 |
| 311681 | metronidazole 500 MG Oral Tablet | SCD | 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | 7 |
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | bff2f5bd-75a4-4252-a643-c21741ae8a96 | 4 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | bff2f5bd-75a4-4252-a643-c21741ae8a96 | 4 |
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | e5850e05-7d71-3210-e053-2a95a90a0837 | 2 |
| 314106 | metroNIDAZOLE 250 MG Oral Tablet | PSN | e5bf5579-4f9c-f2b1-e053-2995a90ae497 | 2 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | e5850e05-7d71-3210-e053-2a95a90a0837 | 2 |
| 314106 | metronidazole 250 MG Oral Tablet | SCD | e5bf5579-4f9c-f2b1-e053-2995a90ae497 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 16571-665-01 | 16571066501 | 100 TABLET in 1 BOTTLE (16571-665-01) | 100 tablet | 2015-05-29 | 0000-00-00 | No | No | Current |
| 16571-665-50 | 16571066550 | 500 TABLET in 1 BOTTLE (16571-665-50) | 500 tablet | 2015-05-29 | 0000-00-00 | No | No | Current |